• Profile
Close

Equal prevalence of severe cervical dysplasia by HPV self-sampling and by midwife-collected samples for primary HPV screening: A randomized controlled trial

European Journal of Cancer Prevention Jun 22, 2021

Hellsten C, Ernstson A, Bodelsson G, et al. - In this randomised study, researchers examined the compliance, prevalence of HPV, and prevalence of severe dysplasia in a vaginal self-sampling group in comparison to cervical samples obtained by midwives (control arm). Per their hypothesis, no difference would be there between vaginal self-sampling and cervical sampling to find high-grade cervical dysplasia or cancer. A total of 14,765 randomly selected women (aged 30–64 years old) were sent vaginal HPV self-sampling kits by regular mail. A follow-up examination was performed by the midwife in HPV-positive women in which a cervical sample was collected for cytological and HPV co-testing. A total of 14,839 women who met the same inclusion criteria and were invited to have cervical sampling by midwives for primary HPV screening were included in the control arm. As per outcomes, a similar proportion of severe dysplasia was detected with the self-sampling approach vs regular screening. Thus, they suggest that primary HPV screening of cervical samples could be replaced with self-sampling.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay